CYTEK BIOSCIENCES INC. - COMMON STOCK

Cytek Biosciences to Participate in Upcoming Investor Conferences

05 2 2025 16:05:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Announces Preliminary Full Year 2024 Revenue Results

15 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

02 1 2025 08:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

30 12 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

20 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

19 11 2024 17:00:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

07 11 2024 17:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Reports Third Quarter 2024 Financial Results

05 11 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

30 10 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024

29 10 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

18 9 2024 17:00:00 提供 Nasdaq GlobeNewswire

Cytek Announces Resignation of Chief Operating Officer Chris Williams

12 9 2024 15:20:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

21 8 2024 17:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Participate in Upcoming Investor Conferences

08 8 2024 16:05:01 提供 Nasdaq GlobeNewswire

Cytek Biosciences Reports Second Quarter 2024 Financial Results

06 8 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

30 7 2024 17:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024

30 7 2024 16:05:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences Announces $50 Million Stock Repurchase Program

06 6 2024 08:00:00 提供 Nasdaq GlobeNewswire

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

30 5 2024 16:05:03 提供 Nasdaq GlobeNewswire

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

28 5 2024 17:30:00 提供 Nasdaq GlobeNewswire